Diabetes pills tested as potential cancer fighter
NCT ID NCT07272057
Summary
This study is testing if adding a common type of diabetes pill (called an SGLT2 inhibitor) to standard cancer treatment can help people who have both advanced lung cancer and type 2 diabetes. Researchers want to see if these pills can help patients live longer or slow down the cancer's growth. They will also carefully check if the pills are safe for the heart and cause any other side effects in this group of patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.